Biofrontera Achieved Two Milestones Associated With Series B-3 Convertible Preferred Stock Warrants; Exercise Of Warrants Will Trigger $8M Payments To Company
Biofrontera實現了與B-3系列可轉換優先股認股權證相關的兩個里程碑;認股權證的行使將觸發向公司支付800萬美元的款項
Biofrontera Achieved Two Milestones Associated With Series B-3 Convertible Preferred Stock Warrants; Exercise Of Warrants Will Trigger $8M Payments To Company
Biofrontera實現了與B-3系列可轉換優先股認股權證相關的兩個里程碑;認股權證的行使將觸發向公司支付800萬美元的款項
使用瀏覽器的分享功能,分享給你的好友吧